RecruitingNCT06107764
Cerebellar Modulation of Cognition in Psychosis
Multiple locations, including BelmontSchizophrenia, BipolarityDevice studyAges 18–55
Study directory
Back to overviewSchizophrenia studies
Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
RecruitingNCT07252206
A Case Series of Culturally-adapted CBTp for Black People in the UK
Official study title
In ManchesterCulturally-adapted Cognitive-behavioural Therapy for Black Sub-Saharan African and Caribbean People Experiencing Psychosis: A Case Series
SchizophreniaBehavioural studyAges 16+
RecruitingNCT04789915
Add-on MEmaNtine to Dopamine Modulation to Improve Negative Symptoms at First Psychosis
Official study title
In Glostrup MunicipalityAMEND - Add-on MEmaNtine to Dopamine Modulation to Improve Negative Symptoms at First Psychosis
SchizophreniaMedication studyAges 18–45
RecruitingNCT01409109
Database Registry for Neural Network Biomarkers in Psychosis
Official study title
In DallasDatabase Registry to Examine Brain Connections and Brain Function in Mental Disorders and Neural Network Biomarkers for Relational Memory and Psychosis in Schizophrenia
SchizophreniaObservational studyAges 18–60
RecruitingACTRN12617000207314
“Quercetin as an augmentation agent in Treatment Resistant Schizophrenia”
In Mount ClaremontSchizophreniaInterventional studyAges 18–60
RecruitingACTRN12619001471178
Bazedoxifene – A New Selective Estrogen Receptor Modulator Treatment for Men with Schizophrenia
Official study title
In AustraliaBazedoxifene – A New Selective Estrogen Receptor Modulator Treatment for Men with Schizophrenia: a double-blind, randomized, placebo controlled trial
SchizophreniaInterventional studyAges 18–65
RecruitingACTRN12605000384651
CONSTA in Polynesian Subjects
Official study title
In New ZealandAn observational study of the impact of long-acting risperidone microspheres on the symptom severity and functional recovery in Maori and Pacific people with schizophrenia and related psychotic disorders
SchizophreniaObservational study
RecruitingACTRN12625001310459
DREAMS: Detection of nocturnal Respiratory Events AMong people living with Schizophrenia.
Official study title
Multiple locations, including RandwickDREAMS: Detection of nocturnal Respiratory Events AMong people living with Schizophrenia: A randomised non-inferiority trial of the effectiveness and cost benefits of 3 nights of home oximetry compared to standard polysomnography for the diagnosis of sleep apnoea.
SchizophreniaInterventional studyAges 18–64
RecruitingNCT06673966
Immunoinflammatory State Detection and Multimodal Brain Imaging and Electrophysiologic Changes in Schizophrenia
In ChangshaSchizophreniaObservational study
RecruitingACTRN12625000992404
Morphofunctional Parameters and Quality of Life of People with Schizophrenia Practicing Nordic Walking
Official study title
In PolandSpecially Designed Exercises Utilizing Nordic Walking and Their Impact on Morphofunctional Parameters, Physical Activity Levels, and Quality of Life in Individuals with Schizophrenia: A Novel Approach to Physical Activation
SchizophreniaInterventional studyAges 18–60
RecruitingACTRN12605000394640
Treatment of Schizophrenia with Aripiprazole. A one year study.
Official study title
Location not clearly listedTreatment of Schizophrenia with Aripiprazole. A one year open-label study examining an ultraslow switchover regime to minimise relapse and withdrawal symptoms.
SchizophreniaInterventional study
Not Yet RecruitingACTRN12626000446369
A program with multiple strategies on self-stigma in people diagnosed with schizophrenia
Official study title
Evaluate the effectiveness of a multicomponent intervention to reduce internalized stigma in people diagnosed with schizophrenia: a randomized clinical trial
This study isn't recruiting yet.
In ChileSchizophreniaInterventional studyAges 35–55
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.